SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-014749
Filing Date
2019-08-09
Accepted
2019-08-09 16:42:16
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 655272
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 31221
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 33548
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13030
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 12980
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6490
  Complete submission text file 0001140361-19-014749.txt   3712751

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bstc-20190630.xml EX-101.INS 625528
8 XBRL TAXONOMY EXTENSION SCHEMA bstc-20190630.xsd EX-101.SCH 28738
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20190630_cal.xml EX-101.CAL 38742
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20190630_def.xml EX-101.DEF 170132
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20190630_lab.xml EX-101.LAB 481362
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20190630_pre.xml EX-101.PRE 280833
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 191013499
SIC: 2834 Pharmaceutical Preparations